Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
They turned out amazing, and since it was my first time she was very thorough when explaining the process, the consultation, and was very professional and sweet
Depending on the medication and the patient population, research and approvals have supported benefits in areas like: Cardiovascular risk reduction in adults with established cardiovascular disease and overweight or obesity (for specific products) Kidney protection in people with type 2 diabetes and chronic kidney disease (semaglutide showed benefit in a large kidney outcomes trial) Obstructive sleep apnea in adults with obesity (tirzepatide has an FDA-approved indication for moderate to severe OSA in this population) Fatty liver disease and MASH (semaglutide has shown promising results in phase 3 research) Addiction to opioids and alcohol This is why these medications are now part of bigger medical conversations: heart, kidney, liver, sleep health and substance abuse
This suggests that a longer treatment duration, comparable to the 72 weeks used in tirzepatide trials, could yield even greater results
This places Louisiana among the highest in the nation. According to the Louisiana Department of Health, the states Medicaid program already spends about $240 million a year on GLP-1 medications for recipients dealing with conditions such as diabetes and liver disease
US$ 28.59
US$ 24.18
US$ 29.61
